Rexahn Pharmaceuticals to Present at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum in New York Feb 18, 2015
Rexahn Pharmaceuticals Announces the Publication of Preclinical Data for Supinoxin(TM) (RX-5902) Demonstrating Mechanism of Action Feb 9, 2015
Rexahn Pharmaceuticals Announces the Appointment of Ely Benaim, M.D., as Chief Medical Officer Feb 4, 2015
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells Jan 6, 2015
Rexahn Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 10, 2014 Dec 4, 2014